Anastasiia S. Boiko
Ph.D., researcher of the Laboratory of Molecular Genetics and Biochemistry, Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Contacts
tel.: 8 (3822) 72-38-32
Brief Biography
Anastasiia S. Boiko, born in 1989, graduated with honors from the Medical-Biological Faculty of the Siberian State Medical University in 2013 with a degree of MD in specialization “Medical biochemistry”. In 2014, she completed her internship and received a diploma in postgraduate professional education and a certificate of a specialist in the specialty 'Clinical Laboratory Diagnostics'. She has a certificate of advanced training in the program “Fundamentals of statistical data processing in scientific research” (Siberian State Medical University; 2016) and a certificate of the training course “R programming, statistics and data analysis” (CEO Blastim, Moscow; 2019). In 2016, she completed training at the European office of Luminex Corporation (‘s-Hertogenbosch, The Netherlands) and became a certified specialist in xMAP Technology in the areas of “Fundamentals of Antigen Coupling” and “Indirect Immunoassay Development”. In the same year, a candidate's thesis was successfully defended on the topic "Clinical and biological characteristics of tardive dyskinesia in schizophrenic patients with long-term antipsychotic therapy" in the specialties “Psychiatry” and “Pathological Physiology”. In December 2023, Anastasia received the academic degree “Doctor of Medical Sciences”, having defended her dissertation on the topic “Clinical and pathobiological patterns of the formation of metabolic syndrome in patients with schizophrenia” (specialty “Psychiatry and Narcology” (medical sciences).
Since 2017, she has been the Chair of the Tomsk Regional Branch of the Early Career Psychiatrists Council of the Russian Society of Psychiatrists (ECP Council of the RSP). She was a member of the Executive Committee of the ECP Council of the RSP as the head of the Research Projects Section from 2017 to 2023. Since 2021, she has been a member of the Council of Young Scientists of the Tomsk Region (https://depvpo.tomsk.gov.ru/people/front/view/id/1503).
Research interests
Scientific interests cover various areas of biological psychiatry and neurology: antipsychotic-induced movement disorders (tardive dyskinesia) in patients with schizophrenia; drug-induced neuroendocrine and metabolic side effects of antipsychotic therapy in patients with mental disorders; study of oxidative stress, immunoinflammation and antioxidant protection, neurotransmitter and neuroprotective systems in patients with schizophrenia and depressive disorders; search for genetic and molecular biological markers of mental and neurodegenerative diseases.
Awards
Laureate of the first degree of the municipal formation 'City of Tomsk' (2011).
Laureate of the scholarship of the Governor of the Tomsk Region (2012).
Laureate of the Tomsk Region Prize in the field of education, science, health, and culture (2012, 2017, 2023).
Laureate of the Prize of the Legislative Duma of the Tomsk Region for young scientists and young talents (2018).
Scholarship of President of Russian Federation for young scientists and graduate students engaged in advanced research and development in priority areas of modernization of the Russian economy: # СП-2392.2015.4 “Investigation of the mechanisms of tardive dyskinesia in schizophrenia and the development of the technology to diagnosis and prognosis” (2015-2017).
Scholarship of President of Russian Federation for young scientists and graduate students engaged in advanced research and development in priority areas of modernization of the Russian economy: # СП-205.2018.4 “Antipsychotic-induced metabolic syndrome in schizophrenia: the investigation of the mechanisms and the development of the personalized technology for prediction the risk” (2018-2020).
Scholarship of President of Russian Federation for young scientists and graduate students engaged in advanced research and development in priority areas of modernization of the Russian economy: # СП-136.221.4 “Markers of immunoinflammation and neuroplasticity: role in the pathogenesis of clinical polymorphism in schizophrenia and development of approaches to personalization of psychopharmacotherapy” (2021-2023).
ECNP Travel Award Winner, 31th ECNP Congress, 6-9 October 2018, Barcelona, Spain;
Gratitude from the Health Protection Committee of the State Duma of the Federal Assembly of the Russian Federation for great achievements in scientific activities and training of qualified specialists (2018).
Winner of Super Fellowship on 3rd World Congress of Early Career Psychiatrists, 12-15 December 2019, Hammamet, Tunisia.
EPA Travel Grant Winner, 28th European Congress of Psychiatry, 28-31 March 2020, Virtual.
Gratitude from the Administration of the Tomsk Region for the great contribution to the development of scientific research and training of highly qualified specialists (2020).
EPA Travel Grant Winner, 29th European Congress of Psychiatry, 10-13 April 2021, Virtual.
Finalist of the leadership competition “Leaders of Russia” on the track 'Science' (2021) of the flagship program of the ANO 'Russia is the Country of Opportunities'.
Certificate of Honor from the Siberian Branch of the Russian Academy of Sciences (2023).
Honorary badge “The Future of the Tomsk Region” (2024).
Honorary badge "Young Scientist" of the Ministry of Science and Higher Education of the Russian Federation (2024).
From 2009 to 2024 Boiko A.S. took part in 26 grants and contracts of the Federal Targeted Program, Russian Science Foundation, Russian Foundation for Basic Research, the President of the Russian Federation, the Program of the Presidium of the Russian Academy of Sciences, etc. (in 5 of them as a head of the project, in 21 as an implementer).
Grants
RSF No. 23-75-10072 “BDNF-mediated intracellular signaling cascades in clinical polymorphism and cognitive deficits in schizophrenia” (head of the project).
• RSF No. 19-75-10012 “New approaches to the pharmacogenetics of metabolic syndrome in schizophrenia” (head of the project).
• Russian Science Foundation No. 23-75-10088 “The role of antioxidant enzymes and nitric oxide synthases in the mechanisms of the formation of metabolic syndrome in schizophrenia.”
• RSF No. 22-15-00084 "Unipolar and bipolar depression: transdiagnosticity or specificity of potential clinical, neurophysiological, molecular biological and metabolomic markers?"
• RFBR No. 18-315-20019 “New approaches to the genetics of clinical polymorphism and neurocognitive deficits in schizophrenia” (head of the project).
• RSF No. 18-15-00011 “Schizophrenia combined with metabolic syndrome: clinical and constitutional factors and molecular markers.”
• RSF No. 17-75-10055 “Pharmacogenetics of tardive dyskinesia in schizophrenia: the role of polymorphisms of muscarinic, adrenergic and glutamate receptor genes” (head of the project).
• RSF No. 21-15-00212 “The role of DNA methylation and polymorphism of glutamatergic system genes in the clinic, cognitive deficit and therapy of schizophrenia.”
• RFBR No. 17-29-06035 “New approaches to the pharmacogenetics of antipsychotic-induced hyperprolactinemia in patients with schizophrenia.”
• RSF 19-15-00023 “Clinical features and search for potential biomarkers of comorbidity of alcoholism and affective disorders.”
• RFBR No. 18-44-700002 “Peripheral biomarkers of stability of therapeutic remission in alcohol dependence.”
• RFBR No. 12-04-33072 “Pathogenesis of motor disorders in patients with endogenous mental disorders during antipsychotic therapy: the role of pharmacogenetic factors.”
• RSF No. 14-15-00480 “Search for biomarkers of socially significant endogenous mental disorders.”
• RFBR No. 14-04-31876 “Excitotoxicity and destructive processes in the pathogenesis of drug-induced movement disorders in patients with schizophrenia” (head of the project).
• RFBR No. 14-04-01157 “Search for biomarkers of depressive and affective disorders.”
• RFBR No. 14-04-31925 “The role of impaired neuroplasticity in the pathogenesis of affective disorders.”
• RSF No. 14-35-00023 “Laboratory of pharmacogenetic research of personalized therapy for mental and neurodegenerative disorders.”
• Grant of the President of the Russian Federation 14.120.14.3854-MK “Neurohumoral systems in the pathogenesis of depressive and affective disorders: search for biomarkers and development of new approaches to diagnosis, prognosis and pharmacotherapy.”
The results of the research were reported and discussed at more than 40 Russian and International congresses, conferences and workshops (Paris, Nice, France; Amsterdam, the Netherlands; Vienna, Austria; Geneva, Switzerland; Barcelona, Spain; Copenhagen, Denmark; Hammamet, Tunisia; Warsaw, Poland; Russian Federation: Tomsk, St. Petersburg, Sudak, Kostroma, Suzdal, Klyazma, Moscow, Volgograd, Novosibirsk etc.).
Repeatedly Boiko A.S. became the winner of competitions for young scientists and was awarded diplomas of various degrees for the best oral and poster presentations (Workshop for Junior Scientists in Europe 2015, competitions for young scientists held within the framework of the All-Russian Schools of Early Career Psychiatrists, 2014, 2015, 2016, 2017, 2018, 2020, etc.).Monographs
1. Metabolic syndrome in patients with schizophrenia: clinical and constitutional features and molecular markers /S.A. Ivanova, E.G. Kornetova, A.S. Boiko, I.A. Mednova, V.V. Khamina, A.V. Semke, N.A. Bokhan. Tomsk: Integrated Casework LLC, 2021: 158 p.
2. Antipsychotic-induced hyperprolactinemia in patients with schizophrenia: social, clinical, immunological and therapeutic features / Kornetova E.G., Ivanova S.A., Tiguntsev V.V., Boiko A.S., Lobacheva O.A., Kornetov A.N., Semke A.V. Tomsk: Integrated Casework LLC, 2019. - 108 p.
3. Schizophrenia: biopsychosocial model and constitutional biological approach / Kornetova E.G., Semke A.V., Kornetov A.N., Ivanova S.A., Lobacheva O.A., Semenyuk K.A., Boiko A. S., Bokhan N.A. Tomsk: Integrated Casework LLC, 2018. - 174 p.
4. Depressive disorders: pathogenesis hypotheses and potential biological markers / S.A. Ivanova, I.S. Losenkov, L.A. Levchuk, A.S. Boiko, N.M. Vyalova, G.G. Simutkin, N.A. Bokhan; Mental Health Research Institute, Vol. National Research Medical Center of the Russian Academy of Sciences. - Novosibirsk: Publishing House of the Siberian Branch of the Russian Academy of Sciences, 2018. - 199 p.
5. Biological markers of schizophrenia: search and clinical application / Boiko A.S., etc. - Novosibirsk: Publisher: Siberian Branch of the Russian Academy of Sciences, 2017. - 148 p.
6. Tardive dyskinesia in patients with schizophrenia: clinic and risk factors / Kornetova E.G., Boiko A.S., Borodyuk Yu.N., Semke A.V. - Tomsk: New Printing Technologies, 2014, 106 p.
Results of Intellectual Activity:
1. Boiko A.S., Mednova I.A., Bocharova A.V., Goncharova A.A., Pozhidaev I.V., Paderina D.Z., Mikhalitskaya E.V., Fedorenko O.Yu., Kornetova E.G., Ivanova S.A. Clinical, biochemical and pharmacogenetic database of patients with schizophrenia with antipsychotic-induced metabolic syndrome / Certificate of registration of the database 2021620680, 04/12/2021. Application No. 2021620592 dated 04/08/2021.
2. Ermakov E.A., Melamud M.M., Boiko A.S., Nevinsky G.A., Buneva V.N. Cytokine profiles and clinical parameters of patients with systemic lupus erythematosus, multiple sclerosis and healthy individuals / Database Registration Certificate 2022620287, 02/04/2022. Application No. 2021622975 dated 12/10/2021.
3. Fedorenko O.Yu., Paderina D.Z., Freidin M.B., Ivanova S.A., Boiko A.S., Kornetova E.G., Pozhidaev I.V., Tiguntsev V.V. Medical decision support program for the choice of antipsychotic therapy for the treatment of patients with schizophrenia, taking into account the risk of developing hyperprolactinemia / Certificate of registration of the program for a computer 2021614034, 03/18/2021. Application No. 2021612250 dated 02/26/2021.
4. Vetlugina T.P., Savochkina D.N., Plotnikov E.V., Boiko A.S., Lobacheva O.A., Bokhan N.A. Agent that induces the production of interleukin-8 / Patent for invention RU 2712785 C1, 01/31/2020. Application No. 2019125218 dated 08/07/2019.
5. Mednova I.A., Ivanova S.A., Boiko A.S., Kornetova E.G., Dubrovskaya V.V., Semke A.V., Bokhan N.A. Method for diagnosing metabolic syndrome in patients with schizophrenia receiving neuroleptic therapy / Patent for invention RU 2717367 C1, 03/23/2020. Application No. 2019108160 dated 03/21/2019.
6. Mednova I.A., Boiko A.S., Kornetova E.G., Dubrovskaya V.V., Ivanova S.A. Database "Clinical and laboratory characteristics of patients with schizophrenia with metabolic syndrome in the process of antipsychotic therapy" / Certificate of registration of the database 2020620990, 06/17/2020. Application No. 2020620843 dated 06/01/2020.
7. Paderina D.Z., Pozhidaev I.V., Boiko A.S., Ivanova S.A. Polymorphic variants of the brain-derived neurotrophic factor gene, neuronal kinase genes and antioxidant enzymes in patients with schizophrenia and healthy individuals / Database Registration Certificate 2020621619, 09/04/2020. Application No. 2020621484 dated 08/28/2020.
8. Levchuk L.A., Roshchina O.V., Simutkin G.G., Boiko A.S., Bokhan N.A., Ivanova S.A. Clinical, dynamic and biological indicators in patients with alcohol dependence syndrome, affective disorders and their comorbidity during psychopharmacotherapy / Database Registration Certificate 2020622477, 12/02/2020. Application No. 2020622314 dated November 23, 2020.
9. Boiko A.S., Pozhidaev I.V., Osmanova D.Z., Kornetova E.G., Ivanova S.A. Database "clinical and pharmacogenetic characteristics of patients with schizophrenia with tardive dyskinesia" / Certificate of registration of the database RU 2019620697, 04/29/2019. Application No. 2019620594 dated 04/18/2019.
10. Paderina D.Z., Tiguntsev V.V., Boiko A.S., Pozhidaev I.V., Kornetova E.G., Ivanova S.A. Database "Clinical and pharmacogenetic characteristics of patients with schizophrenia with antipsychotic-induced hyperprolactinemia" / Certificate of registration of the database RU 2019621451, 08/13/2019. Application No. 2019621354 dated 08/06/2019.
11. Ivanova S.A., Smirnova L.P., Semke A.V., Krotenko N.M., Rudikov E.V., Ivanova (Boiko) A.S., Kornetova E.G. Method for predicting the risk of developing tardive dyskinesia during neuroleptic therapy of patients with schizophrenia / Patent for invention RU 2447832 C1, 04/20/2012. Application No. 2010151648/14 dated December 15, 2010.
Articles
1. Boiko A.S., Paderina D.Z., Mikhalitskaya E.V., Kornetova E.G., Bokhan N.A., Ivanova S.A. Pilot Study of the DRD3, GHRL, FTO, LEPR, INSIG2, GSTP1, and ABCB1 Gene Expression in Peripheral Blood Leukocytes in Schizophrenic Patients with Metabolic Syndrome. Neurochemical Journal, 2024; 18(1): 29–35. https://doi.org/10.1134/S1819712424010045
2. Kornetova E.G., Galkin S.A., Mednova I.A., Tiguntsev V.V., Boiko A.S., Kornetov A.N., Ivanova S.A., Bokhan N.A. Associations between components of the metabolic syndrome and cognitive impairment in patients with schizophrenia. Journal of Neurology and Psychiatry. S.S. Korsakov. 2024; 124(3): 82 87. https://doi.org/10.17116/jnevro202412403182
3. Mednova IA, Pozhidaev IV, Tiguntsev VV, Bocharova AV, Paderina DZ, Boiko AS, Fedorenko OY, Kornetova EG, Bokhan NA, Stepanov VA, Ivanova SA. NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia. Biomedicines. 2024; 12(3): 627. https://doi.org/10.3390/biomedicines12030627
4. Nikitina M.A., Bragina E.Yu., Nazarenko M.S., Levchuk L.A., Ivanova S.A., Boiko A.S., Gomboeva D.E., Koroleva E.S., Alifirova V.M. Association of the rs6265 polymorphism of the BDNF gene with the level of serum neurotrophic factor in patients with Parkinson's disease. Journal of Neurology and Psychiatry. S.S. Korsakov. 2024; 124(1): 114 120. https://doi.org/10.17116/jnevro2024124011114
5. Ermakov E.A., Mednova I.A., Boiko A.S., Buneva V.N., Ivanova S.A. Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review // Int. J. Mol. Sci. 2023, 24, 2215. https://doi.org/10.3390/ijms24032215
6. Boiko A.S., Mednova I.A., Kornetova E.G., Semke A.V., Bokhan N.A., Ivanova S.A. Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome // Metabolites. 2023; 13: 376. https://doi.org/10.3390/metabo13030376
7. Kamaeva D.A., Kazantseva D.V., Boiko A.S., Mednova I.A., Smirnova L.P., Kornetova E.G., Ivanova S.A. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia. Biomedicines. 2023; 11(4): 1179. https://doi.org/10.3390/biomedicines11041179
8. Boiko A.S., Mednova I.A., Kornetova E.G., Bokhan N.A., Ivanova S.A. Serum Growth Factors in Schizophrenia Patients. Current Issues in Molecular Biology. 2023; 45(4):3291-3301. https://doi.org/10.3390/cimb45040215
9. Kozyrev E.A., Ermakov E.A., Boiko A.S., Mednova I.A., Kornetova E.G., Bokhan N.A., Ivanova S.A. Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers // Biomedicines. 2023; 11(7):1990. https://doi.org/10.3390/biomedicines11071990
10. Ermakov E.A., Melamud M.M., Boiko A.S., Kamaeva D.A., Ivanova S.A., Nevinsky G.A., Buneva V.N. Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data // Brain Sci. 2023, 13, 836. https://doi.org/10.3390/brainsci13050836
11. Tiguntsev V.V., Gerasimova V.I., Kornetova E.G., Fedorenko O.Yu., Kornetov A.N., Goncharova A.A., Poltavskaya E.G., Boiko A.S. Association of serum prolactin levels with polymorphic variants of the GRIN2A, GRM3, GRM7 genes in patients with schizophrenia taking conventional and atypical antipsychotics // Molecular Biology. – 2023. – T. 57, No. 1. – P.47-55. DOI: 10.31857/S0026898423010159
12. Titova M.A., Alifirova V.M., Kamenskikh E.M., Musina N.F., Nikolaeva T.N., Paderina D.Z., Boiko A.S., Ivanova S.A. RS6265 polymorphism of the BDNF gene in the population of patients with multiple sclerosis in the Tomsk region. Journal of Neurology and Psychiatry. S.S. Korsakov. 2023;123(5):160 164. https://doi.org/10.17116/jnevro2023123051160
13. Tarabrina A.A., Ogorodova L.M., Samoilova Yu.G., Fedosenko S.V., Fedorova O.S., Petrov V.A., Podchinenova D.V., Boiko A.S. Cytokine profile in obesity and bronchial asthma in children // Bulletin of Siberian Medicine. – 2023. – T. 22, No. 2. – P. 97-103. DOI 10.20538/1682-0363-2023-2-97-103
14. Poltavskaya E.G., Tiguntsev V.V., Boiko A.S., Kornetova E.G., Ivanova S.A., Fedorenko O.Yu. Study of Associations of the GRM8 Gene with Antipsychotic-induced Hyperprolactinemia // Personalized Psychiatry and Neurology 2023, 3 (1): 42-47. https://doi.org/10.52667/2712-9179-2023-3-1-42-47
15. Boiko AS, Pozhidaev IV, Paderina DZ, Mednova IA, Goncharova AA, Fedorenko OY, Kornetova EG, Semke AV, Bokhan NA, Loonen AJM, Ivanova SA. Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome. Genes. 2022; 13(5):844. https://doi.org/10.3390/genes13050844 (Web of Science)
16. Paderina DZ, Boiko AS, Pozhidaev IV, Mednova IA, Goncharova AA, Bocharova AV, Fedorenko OY, Kornetova EG, Semke AV, Bokhan NA, Loonen AJM, Ivanova SA. The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes (Basel). 2022 Jul 23;13(8):1312. doi: 10.3390/genes13081312 (Web of Science)
17. Mednova IA, Levchuk LA, Boiko AS, Roschina OV, Simutkin GG, Bokhan NA, Loonen AJM, Ivanova SA. Cytokine level in Patients with Mood Disorder, Alcohol Use Disorder and their Comorbidity. World J Biol Psychiatry. 2022 Jul 12:1-42. doi: 10.1080/15622975.2022.2095439 (Web of Science, Scopus)
18. T. P. Vetlugina, V. D. Prokopieva, E. V. Epimakhova, A. S. Boiko, V. B. Nikitina, and N. A. Bokhan. Cytokine Production in Whole Blood Cells Culture of Patients with Alcohol Dependence and Autologous Plasma Oxidative Stress Markers. Bulletin of Experimental Biology and Medicine. No. 1, May, 2022. Р. 151-154. DOI 10.1007/s10517-022-05511-5. (Web of Science)
19. Melamud Mark M., Ermakov Evgeny A., Boiko Anastasiia S., Parshukova Daria A., Sizikov Alexey E., Ivanova Svetlana A., Nevinsky Georgy A., Buneva Valentina N. Serum cytokine levels of systemic lupus erythematosus patients in the presence of concomitant cardiovascular diseases // Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22 . https://dx.doi.org/10.2174/1871530322666220304214512 (Web of Science, Scopus)
20. T. P. Vertlugina, V. D. Prokopjeva, E. V. Epimakhova, A. S. Boiko, V. B. Nikitina, N. A. Bokhan Cytokine production in whole blood cells culture of patients with alcohol dependence and autologous plasma oxidative stress markers // Cell Technologies in Biology and Medicine. 2022. №1. С. 45–48. DOI: 10.47056/1814-3490-2022-1-45-48. (Web of Science)
21. Boiko A.S., Mednova I.A., Kornetova E.G., Gerasimova V.I., Kornetov A.N., Loonen A.J.M., Bokhan N.A., Ivanova S.A. Cytokine level changes in schizophrenia patients with and without metabolic syndrome treated with atypical antipsychotics // Pharmaceuticals 2021, 14(5), 446. (Web of Science, Scopus)
22. Boiko AS, Pozhidaev IV, Paderina DZ, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA. Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients. Pharmgenomics Pers Med. 2021;14:1123-1131 https://doi.org/10.2147/PGPM.S327353 (Web of Science)
23. Elena G. Kornetova, Alexander N. Kornetov, Irina A. Mednova, Anastasia A. Goncharova, Valeria I. Gerasimova, Ivan V. Pozhidaev, Anastasia S. Boiko, Arkadiy V. Semke, Anton J.M. Loonen, Nikolay A. Bokhan, Svetlana A. Ivanova (2021). Comparative characteristics of the metabolic syndrome prevalence in patients with schizophrenia in three Western Siberia psychiatric hospitals. Front. Psychiatry. 12:661174021. doi:10.3389/fpsyt.2021.661174 (Web of Science; Scopus)
24. Roschina, O.V.; Levchuk, L.A.; Boiko, A.S.; Michalitskaya, E.V.; Epimakhova, E.V.; Losenkov, I.S.; Simutkin, G.G.; Loonen, A.J.M.; Bokhan, N.A.; Ivanova, S.A. Beta-Endorphin and Oxytocin in Patients with Alcohol Use Disorder and Comorbid Depression. J. Clin. Med. 2021, 10, 5696. https://doi.org/10.3390/jcm10235696 (Web of Science, Scopus)
25. Paderina DZ, Boiko AS, Pozhidaev IV, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA. Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia // Journal of Personalized Medicine. 2021; 11(3):181 (Web of Science, Scopus)
26. Vetlugina T.R., Epimakhova E.V., Savochkina D.N., Plotnikov E.V., Boiko A.S., Ivanova S.A., Bokhan N.A. Estimation of the effect of lithium salts on cytokine production by blood cells in in vitro experiments. Bulletin of Siberian Medicine. 2021;20(3):21-28. https://doi.org/10.20538/1682-0363-2021-3-21-28 (Web of Science)
27. A.S. Boiko, I.A. Mednova, E.G. Kornetova, N.A. Bokhan, A.V. Semke, A.J.M. Loonen, S.A. Ivanova. Cortisol and DHEAS related to metabolic syndrome in patients with schizophrenia // Neuropsychiatric Disease and Treatment. 2020;16:1051-1058. (Web of Science, Scopus)
28. Boiko A.S., Ivanova S.A., Pozhidaev I.V., Freidin M.B., Osmanova D.Z., Fedorenko O.Y., Semke A.V., Bokhan N.A., Wilffert B., Loonen A.J.M. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors // World J Biol Psychiatry. 2020 Jan;21(1):72-77. (Web of Science, Scopus)
29. A. Boiko, E. Mikhalitskaya, E. Kornetova, S. Ivanova Cognitive functions and a BDNF gene polymorphism in schizophrenia patients and healthy individuals // Cognitive Sciences, Genomics and Bioinformatics (CSGB), 2020, pp. 65-67. (Scopus)
30. Mednova I.A., Boiko A.S., Kornetova E.G., Parshukova D.A., Semke A.V., Bokhan N.A., Loonen A.J.M., Ivanova S.A. Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia // Metabolites 2020, 10(10), 410. (Web of Science, Scopus)
31. I.V. Pozhidaev, A.S. Boiko, A.J.M. Loonen, D.Z. Paderina, O.Yu. Fedorenko, G. Tenin, E.G. Kornetova, A.V. Semke, N.A. Bokhan, B.Wilffert, S.A. Ivanova Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia // The Application of Clinical Genetics. 2020. Volume 2020:13 Pages 97—105. (Scopus)
32. Fedorenko O.Y., Paderina D.Z., Loonen A.J.M., Pozhidaev I.V., Boiko A.S., Kornetova E.G., Bokhan N.A., Wilffert B., Ivanova S.A. Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia // Hum Psychopharmacol. 2020. 8:e2737. (Web of Science, Scopus)
33. Losenkov I.S., Mulder N.J.V., Levchuk L.A., Vyalova N.M., Loonen A.J.M., Bosker F.J., Simutkin G.G., Boiko A.S., Bokhan N.A., Wilffert B., Hak E., Schmidt A.F., Ivanova S.A. Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients // Front. Psychiatry 2020 11:38. (Web of Science, Scopus)
34. Geers L.M., Pozhidaev I.V., Ivanova S.A., Freidin M.B., Schmidt A.F., Cohen D., Boiko A.S., Paderina D.Z., Fedorenko O.Y., Semke A.V., Bokhan N.A., Wilffert B., Kosterink J.G.W., Touw D.J., Loonen A.J.M. Association between eight P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinemia // Br J Clin Pharmacol. 2020;86(9):1827-1835. (Web of Science, Scopus)
35. Levchuk L.A., Meeder E.M.G., Roschina O.V., Loonen A.J.M., Boiko A.S., Michalitskaya E.V., Epimakhova E.V., Losenkov I.S., Simutkin G.G., Bokhan N.A., Schellekens A.F.A., Ivanova S.A. Exploring Brain Derived Neurotrophic Factor and Cell Adhesion Molecules as Biomarkers for the Transdiagnostic Symptom Anhedonia in Alcohol Use Disorder and Comorbid Depression // Front. Psychiatry (2020) 11:296. (Web of Science, Scopus)
36. S. Ivanova, D. Paderina, A. Boiko, O. Fedorenko, I. Pozhidaev, V. Tigunsev, E. Kornetova, N. Bokhan, B. Wilffert, A. Loonen COMT gene polymorphism and antipsychotic- induced hyperprolactinemia in schizophrenia patients // Cognitive Sciences, Genomics and Bioinformatics (CSGB), 2020, pp. 80-84. (Scopus)
37. Koroleva E.S., Tolmachev I.V., Alifirova V.M., Boiko A.S., Levchuk L.A., Loonen A.J.M., Ivanova S.A. Serum BDNF’s Role as a Biomarker for Motor Training in the Context of AR-Based Rehabilitation after Ischemic Stroke // Brain Sci. 2020, 10, 623. (Web of Science, Scopus)
38. Boiko A.S., Mednova I.A., Kornetova E.G., Semke A.V., Bokhan N.A., Loonen A.J.M., Ivanova S.A. Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia // Heliyon. Volume 5, Issue 7, July 2019, e02033. (Web of Science, Scopus)
39. Levchenko A., Vyalova N., Pozhidaev I.V., Boiko A.S., Osmanova D.Z., Fedorenko O.Y., Semke A.V., Bokhan N.A., Wilffert B., Loonen A.J.M., Ivanova S.A. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia // Hum Psychopharmacol. 2019 Jan 8:e2685. (Web of Science, Scopus)
40. Osmanova D.Z., Freidin M.B., Fedorenko O.Yu., Pozhidaev I.V., Boiko A.S., Vyalova N.M., Tiguntsev V.V., Kornetova E.G., Loonen A.J.M., Semke A.V., Wilffert B., Bokhan N.A., Ivanova S.A. A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia // BMC Medical Genetics. 2019, 20 (Suppl 1):47. (Web of Science, Scopus)
41. Kornetova E.G., Kornetov A.N., Mednova I.A., Dubrovskaya V.V., Boiko A.S., Bokhan N.A., Loonen A.J.M., Ivanova S.A. Changes in body fat and related biochemical parameters associated with atypical antipsychotic drug treatment in schizophrenia patients with or without metabolic syndrome // Front. Psychiatry. 2019. Vol. 10: A. 803. (Web of Science, Scopus)
42. Kornetov A.N., Kornetova E.G., Golenkova A.V., Kozlova S.M., Arzhanik M.B., Samoylenko Z.A., Boiko A.S., Semke A.V. Neurocognitive deficits in clinical polymorphism of schizophrenia: typology, expression and syndromal overlaps // Bulletin of Siberian Medicine. 2019;18(2):107-118. (In Russ.) (Web of Science).
43. Koroleva E.S., Alifirova V.M., Brazovskaya N.G., Plotnikov D.M., Levchuk L.A., Boiko A.S., Zapekin S.G., Semenenko A.S., Kataeva N.G., Ivanova S.A. Clinical and laboratory assessment of the effectiveness of early rehabilitation of patients with stroke using assistive robotic tools. Bulletin of Siberian Medicine. 2019;18(4):55-62. (In Russ.) (Web of Science; Scopus)
44. Losenkov I. S., Boiko A. S., Levchuk L. A., Simutkin G. G., Bokhan N. A., Ivanova S. A. Blood-Serum Glutamate in Patients with Depressive Disorders as a Potential Peripheral Marker of the Prognosis of the Effectiveness of Therapy // Neurochem. J. 2018, 12, 366–372. (Web of Science; Scopus)
45. Fedorenko O.Yu., Loonen A.J.M., Vyalova N.M., Boiko А. S., Pozhidaev I.V., Osmanova D.Z., Rakhmazova L.D., Bokhan N.А., Ivanov M.V., Freidin M.B., Ivanova S.А. Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia // Physiol Pharmacol 2017, 21(1):25-33. (Web of Science; Scopus)
46. Ivanova S.A., Osmanova D.Z., Boiko A.S., Pozhidaev I.V., Freidin M.B., Fedorenko O.Y., Semke A.V., Bokhan N.A., Kornetova E.G., Rakhmazova L.D., Wilffert B., Loonen A.J. Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics // Schizophr Res. 2017 Apr;182:110-114. (Web of Science; Scopus)
47. Ivanova S.A., Osmanova D.Z., Freidin M.B., Fedorenko O.Y., Boiko A.S., Pozhidaev I.V., Semke A.V., Bokhan N.A., Agarkov A.A., Wilffert B., Loonen A.J. Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinemia in antipsychotic drug-treated schizophrenic patients // World J. Biol. Psychiatry. 2017 Apr;18(3):239-246. (Web of Science; Scopus)
48. V.D. Prokopjeva, E.G. Yarygina, N.M. Krotenko, A.S. Boiko, N.A. Bohan, S.A. Ivanova Indicators of the antioxidant system and dopamine in blood plasma in the dynamics of microwave resonance therapy in patients with alcoholism // Zh Nevrol Psikhiatr Im S S Korsakova, 9, 2017. – с.67-70. (Web of Science; Scopus) (In Russ.)
49. Ivanova S. A., Toshchakova V. A., Filipenko M. L., Fedorenko O. Y., Boyarko E.G., Boiko A. S., Semke A. V., Bokhan N. A., Aftanas L. I., Loonen A. J. Cytochrome P450 1A2 codetermines neuroleptic load and may diminish tardive dyskinesia by increased inducibility // World J. Biol. Psychiatry, 2015 Apr;16(3):200-205. (Web of Science Q1; Scopus)
50. Ivanova S.A., Alifirova V.M., Zhukova I.A., Boiko A.S., Fedorenko O.Y., Zhukova N.G., Bokhan N.A. The association of the DRD3 gene with Parkinson's disease // Zh Nevrol Psikhiatr Im S S Korsakova, 2016;116(5):71-74. (Web of Science; Scopus)
51. Smirnova L.P., Ermakov E.A., Boiko A.S., Bokhan N.A., Semke A.V., Ivanova S.A. Antibodies to native and denatured DNA in the serum of patients with schizophrenia depending on the clinical features of the disease // Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(4): 47-51. (Web of Science; Scopus)
52. Fedorenko O.Y., Vyalova N.M., Boiko А.S., Pozhidaev I.V., Osmanova D.Z., Rakhmazova L.D., Bokhan N.А., Ivanova S.А., Loonen A.J.M., Ivanov M.V., Freidin M.B. Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia // Physiology and Pharmacology. 2017;21(1):25-33. (Web of Science; Scopus)
53. Kornetova Y.G., Semke A.V., Dmitrieva Y.G., Borodyuk Y.N., Boiko A.S. Clinical and social risk factors of tardive dyskinesia in patients with schizophrenia during antipsychotic treatment // Bulletin of Siberian Medicine. 2015;14(1):32-39. (In Russ.) (Web of Science)
54. Ivanova S. A., Boiko A. S., Fedorenko O. Yu., Krotenko N. M., Semke A. V., BokhanN. A. Glutamate concentration in the serum of patients with schizophrenia // Procedia Chemistry 10(2014) 80 – 85. (Scopus)
55. Ivanova S. A., Smirnova L. P., Shchigoreva Yu. G., Boiko A. S., Semke A. V., Uzbekov M. G., Bokhan N. A. Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics // Neurochemical Journal, 2014, Vol. 8, No. 1, pp. 66–70. (Web of Science; Scopus)
56. Bokhan N. A., Mandel A. I., Abolonin A. F., Liashenko G. P., Kisel N. I., Molkina L. G., Boiko A. S., Ivanova S. A. The role of reamberin in combined therapy of abstinence syndrome in alcoholics // Klin Med (Mosk). 2012;90(11):57-61. (In Russ.). (Scopus)
57. Krotenko N.M., Boiko A.S., Yepanchintseva Y.M., Ivanova S.A. Parameters oxidative stress and endogenous intoxication of peripheral blood in patients with exogenous organic disorders indynamic of the pharmacotherapy // Bulletin of Siberian Medicine. 2012;11(1):179-184. (In Russ.). (Web of Science)